Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Guangzhou Pharmaceutical Co Ltd Announces Chairman Change

Thursday, 8 Aug 2013 08:17am EDT 

Guangzhou Pharmaceutical Co Ltd announced that Mr. Yang Rongming (Mr. Yang) has resigned as an Executive Director, Chairman of the Company and the chairman of the Strategic Development and Investment Committee with effect from August 8, 2013, as he has reached the age of statutory retirement. It follows that he also ceased to be the authorized representative of the Company on August 8, 2013. Following the resignation of Mr. Yang, the Board announced that Mr. Li Chuyuan (Mr. Li), currently an executive director of the Company, has been appointed as the Chairman of the Company with effect from August 8, 2013.